BioCryst Pharma (BCRX) PT Raised to $25 at Cowen on Orladeyo Sales Data
Tweet Send to a Friend
Cowen analyst Ken Cacciatore raised the price target on BioCryst Pharma (NASDAQ: BCRX) to $25.00 (from $23.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
